What is Microvi Biotech?
Headquartered in Hayward, California, Microvi Biotech specializes in the development of high-efficiency solutions for clean drinking water. The company operates at the intersection of biotechnology and environmental engineering, providing scalable filtration systems designed to mitigate nitrate contamination. Beyond its core product offerings, Microvi Biotech maintains a robust research division, facilitating extensive case studies that validate the efficacy of its biological and chemical filtration processes. This dual focus on technological deployment and empirical research positions the firm as a leader in the water treatment industry, catering to both municipal and industrial clients seeking sustainable, long-term water quality management.
How much funding has Microvi Biotech raised?
Microvi Biotech has raised a total of $1.4M across 3 funding rounds:
Series A
$1M
Debt
$150K
Debt
$217K
Series A (2009): $1M with participation from Perry Solomon
Debt (2020): $150K led by PPP
Debt (2021): $217K supported by PPP
Key Investors in Microvi Biotech
PPP
Public-Private Partnership
Perry Solomon
An individual investor with a history of supporting early-stage ventures in the biotechnology and environmental sectors.
What's next for Microvi Biotech?
With the recent influx of capital, Microvi Biotech is poised to accelerate its market penetration and expand its research capabilities. The strategic focus will likely shift toward optimizing its filtration infrastructure for larger-scale municipal projects, where the demand for cost-effective nitrate removal is most acute. As the company transitions from its established growth phase into a more mature enterprise-level operation, it will likely prioritize the commercialization of its latest research findings. This evolution will be critical in maintaining its competitive edge against traditional water treatment methodologies, ensuring that Microvi Biotech remains at the forefront of the global transition toward sustainable water security.
See full Microvi Biotech company page
